期刊文献+
共找到1,203篇文章
< 1 2 61 >
每页显示 20 50 100
COMPUTER-ASSISTED TESTING OF METALINGUISTIC COMPETENCE
1
作者 Baisara Ludmila 《广州大学学报(社会科学版)》 1995年第2X期96-100,共5页
The paper is devoted to the description of possible approaches to designing materials for computer-assisted testing of metalinguistic competence of the intending foreign language teachers. By metalinguistic competence... The paper is devoted to the description of possible approaches to designing materials for computer-assisted testing of metalinguistic competence of the intending foreign language teachers. By metalinguistic competence we here mean the learners’ comprehension of such fundamental concepts of linguistic theory as: grammatical and lexical meanings and their types, the concepts of grammatical form and grammatical category, homonyms and synonyms, 展开更多
关键词 computer-assisted testING OF METALINGUISTIC COMPETENCE
在线阅读 下载PDF
Clinical evaluation of HPV DNA test combined with liquid-based cytology in the diagnosis of cervical disease 被引量:2
2
作者 Raghvendra Thakur Jasma Mally +5 位作者 Rajina Shrestha Xuehua Zheng Mengli Zhang Yanjun Wu Neelima Bajracharya Guiying Zheng 《Open Journal of Obstetrics and Gynecology》 2013年第3期371-376,共6页
Objectives: To evaluate the sensitivity and accuracy of the HPV DNA test in conjunction with thin prep cytology test as a screening method of human papillomavirus (HPV) infection. To study either the cervical erosion ... Objectives: To evaluate the sensitivity and accuracy of the HPV DNA test in conjunction with thin prep cytology test as a screening method of human papillomavirus (HPV) infection. To study either the cervical erosion is related to high risk HPV infection or to determine the mean age distribution that is more prone to HPV infection. Material and Methods: The study is a retrospective cohort implemented to determine the real performance of liquid based medium and HPV DNA testing combined in second clinical hospital of Jilin University Changchun, China. The study group included total 150 patients from January 1, 2011 to December 30, 2012. A computerized search identified patients with thin prep test results and high risk HPV DNA testing during a 2-year period was recruited. The patients were chosen after proper speculum examination followed by thin prep cytology (TCT) and HPV DNA test. Cytologic specimens were obtained with endocervical brush, which was rinsed into the vial of Cytyc. The residual samples after the cytology report were taken for reflex HPV DNA test. The manufacture protocol was followed for HPV DNA testing using Hybrid Capture II. Colposcopic biopsy was performed for the diagnosis purpose, in patients who had atypical squamous cells of undeter-mined significance (AUS-US), low grade intraepithelial lesion (LSIL) or high-grade intraepithelial lesion (HSIL) in cytology and with positive results of highrisk HPV DNA. The diagnostic criteria were based on the Bethesda System (TBS). Findings: The high risk HPV positive women with abnormal cytology had a CIN I risk of 73 (86%), whereas 35 (23.3%) high-risk HPV positive women out of 109 (72.7%) normal cytology who underwent histological biopsy had CIN I 16 (10.7%). The risk for cervical intraepithelial neoplasia (CIN) in women with high-risk HPV positive with normal cytology was higher among women invited for the first time 31 - 40 years of age 12 (8%) than among older women 1 (0.7%). Out of 44 (29.3%) women who had I degree erosion with 6 (14%) positive HPV DNA test 38 (86%) had a normal histology biopsy showing no statically significant between them. Conclusion: The data confirm that HR-HPV DNA testing is much more sensitive than cytology alone and that HPV DNA testing helps in identifying women with high risk of serious cervical disease in an efficient and medically acceptable manner. The other most significant advantage of this cervical cancer screening method is that women who are HPV DNA positive can easily and quickly referred for colposcopic examination (within one year), which could identify the precancerous and cancer stage. And those who are HPV DNA negative can safely have much longer screening intervals saving considerable costs. With mean age being 38 ± 10 years, age older than 30 years should undergo HPV DNA testing with cytology triage in primary screening. But in woman younger than 30 years using HPV DNA assay, as an initial screening step can increase the prevalence of abnormal smears and the positive predictive value of HPV followed by TCT. However, close follow-up is essential if the initial biopsy is negative because a considerable number of women may have HPV infection positive in subsequent studies. 展开更多
关键词 Human PAPILLOMAVIRUS Thin-Prep cytologY test Hybrid Capture Cervical Intraepithelial NEOPLASIA BETHESDA System COLPOSCOPY Examination
暂未订购
Cytological Changes of Oral Cavity and of High/Low Risk HPV Detection in Women with Cervical Pathology
3
作者 Nestan Shonia Keti Gogilashvili +2 位作者 Irina Mepharishvili Teona Muzashvili George Burkadze 《Health》 2015年第6期715-722,共8页
Oropharyngeal tumor is the eight most common cause of cancer death worldwide. Among the causes of oropharyngeal carcinoma significant are cigarette smoking, abuse of alcohol, multi-partners, high risk HPV (Human Papil... Oropharyngeal tumor is the eight most common cause of cancer death worldwide. Among the causes of oropharyngeal carcinoma significant are cigarette smoking, abuse of alcohol, multi-partners, high risk HPV (Human Papillomavirus) and etc. Cytological material (oral Pap smear) was taken from oral fundus and cheek mucous by the cytobrush. 47 participants with cervix pathology and 42 participants of the control group were investigated. Oral smears were stained by the Papanicolaou method and were diagnosed by a double blind method. After the cytological examination, we carried out detecting low and high risk HPV by chromogenic in-situ hy-bridization (CISH method) to use a positive and negative control. The quantitative statistical analysis was performed by SPSS V.19.0. Numeral data were processed using Pearson correlation and X2 tests. Confidence interval of 95% was regarded statistically significant. Study group’s oral pap smear with atypical cytology was detected in 61.7%. Atypical cytological changes in the control group were confirmed in 38.0%. High risk HPV detection by the CISH, in study group, showed positivity in 46.8% and in the control group—in 4.8%. Participants with cervix pathology will be considered as a risk-group to develop oropharyngeal tumor. Screening program for oropharyngeal cancer combines Pap smear and high risk HPV test together. For the control group, it is recommended to use oral pap smear and in the case of atypical changes using high risk HPV test too. 展开更多
关键词 OROPHARYNGEAL Cancer Oral cytologY PAP SMEAR HPV test CISH
暂未订购
Follow-up study on ThinPrep cytology test-positive patients in tropical regions
4
作者 Yun-Chun Chen Chong-Nan Liang +3 位作者 Xiang-Feng Wang Min-Fa Wang Xu-Ning Huang Jian-Dong Hu 《World Journal of Clinical Cases》 SCIE 2022年第34期12543-12550,共8页
BACKGROUND As shown in the statistics from the World Health Organization,it is estimated that approximately 75000 new cases of cervical cancer occur every year in China.In 2008,33000 people died of cervical cancer in ... BACKGROUND As shown in the statistics from the World Health Organization,it is estimated that approximately 75000 new cases of cervical cancer occur every year in China.In 2008,33000 people died of cervical cancer in China.It is proven that most women are at risk of cervical cancer.The progression from human papillomavirus(HPV)infection to cervical cancer can be several years or decades,which offers a unique opportunity to prevent cancer.AIM To observe the changes in ThinPrep cytology tests(TCT)and HPV infection in patients who were detected to be positive via TCT screening of cervical cancer and further explore the biopsy results.METHODS This paper performed a follow-up study on 206 cervical cancer screening-positive patients of 12231 total cases from our previous research.We conducted an observational study on the TCT results based on the interpretation of The Bethesda System.RESULTS Over a 5-year period,10 cases received consistent follow-up.The proportions of cases in which glandular epithelial lesions were detected increased over the follow-up period.The differences between the years were statistically significant(P<0.01).Over the 5 years,the proportion of patients whose squamous epithelial lesions transformed into glandular epithelial lesions increased yearly.Annual positive rates of HPV infection were:year 1,73%(24/33);year 2,43%(6/14);year 3,36%(9/25);year 4,50%(9/18);and year 5,25%(6/24).The positive detection rate after biopsy over a 9-year period was 29%.CONCLUSION The follow-up study for 5 years to 9 years revealed a tendency to change from squamous epithelial lesions to glandular epithelial lesions and an improvement of the disease(which had not been reported previously).The HPV test indicated a high negative conversion ratio of the viral infection.However,the follow-up cases were not found to have persistent infection of high-risk HPV.Therefore,early intervention of cervical cancer screening is necessary.Low re-examination compliance,patient education,and preventive measures should be enhanced. 展开更多
关键词 Cervical cancer ThinPrep cytology test screening Human papillomavirus Follow-up study SCREENING Tropical regions
暂未订购
甲基化检测在绝经后女性子宫颈病变的预警效能研究
5
作者 顾辰洁 石慧 +1 位作者 马昕宇 邢燕 《实用妇产科杂志》 北大核心 2026年第3期223-228,共6页
目的:探讨子宫颈脱落细胞中ZNF671、SOX17、ASTN1、DLX1、ITGA4、RXFP36种宿主基因甲基化检测对绝经后子宫颈病变的预警效能。方法:选择2023年6月1日至2024年3月31日于南京医科大学第一附属医院妇科就诊的128例绝经后患者为研究对象,对... 目的:探讨子宫颈脱落细胞中ZNF671、SOX17、ASTN1、DLX1、ITGA4、RXFP36种宿主基因甲基化检测对绝经后子宫颈病变的预警效能。方法:选择2023年6月1日至2024年3月31日于南京医科大学第一附属医院妇科就诊的128例绝经后患者为研究对象,对其子宫颈脱落细胞样本中6种基因甲基化水平进行检测。对患者的高危型人乳头瘤病毒(HR-HPV)分型检测、薄层液基细胞学检测(TCT)及甲基化检测结果与阴道镜下活检的病理结果进行比较,分析甲基化检测与TCT对阴道镜下病理结果为CIN2及以上(CIN2^(+))的诊断效能并绘制受试者工作特征(ROC)曲线,比较甲基化检测与行子宫颈环形电切术(LEEP)后的病理结果。结果:①6种基因甲基化检测阳性28例,阴性100例。HR-HPV阴性、单一感染、多重感染组间甲基化阳性率差异无统计学意义(P>0.05)。HPV16感染的甲基化阳性率最高为32.14%。不同TCT等级间甲基化阳性率差异无统计学意义(P>0.05)。②甲基化阳性与阴性患者、不同TCT等级间CIN2^(+)比例的差异有统计学意义(P<0.05)。甲基化检测对CIN2^(+)的敏感度为62.50%,特异度为87.50%,曲线下面积(AUC)及与病理结果一致性均优于HPV16/18检测及TCT。③在行LEEP治疗的29例患者中,甲基化阳性12例,阴性17例,病理为CIN2^(+)的患者甲基化阳性率高达62.50%,阳性患者中LEEP术后病理与活检病理一致或升级(100.00%);阴性患者中有15例病理结果一致或降级(88.24%)。结论:6种宿主甲基化检测可作为绝经后女性子宫颈病变辅助检测手段,提高该年龄段女性子宫颈病变预警的效能,实现更精准的诊治。 展开更多
关键词 甲基化检测 人乳头瘤病毒分型 薄层液基细胞学 绝经后女性 子宫颈病变
暂未订购
上海地区不同宫颈病变患者人乳头瘤病毒基因型分布
6
作者 张超敏 杨迟晖 +1 位作者 易长林 陆文苑 《检验医学》 2026年第2期182-185,共4页
目的分析上海地区不同宫颈病变患者人乳头瘤病毒(HPV)基因型分布,为宫颈癌筛查提供参考。方法选取2019年7月—2023年12月上海交通大学医学院附属瑞金医院4121例女性HPV感染者,分别进行HPV基因型检测和液基细胞学检查(TCT)。结果4121例女... 目的分析上海地区不同宫颈病变患者人乳头瘤病毒(HPV)基因型分布,为宫颈癌筛查提供参考。方法选取2019年7月—2023年12月上海交通大学医学院附属瑞金医院4121例女性HPV感染者,分别进行HPV基因型检测和液基细胞学检查(TCT)。结果4121例女性HPV感染者中,TCT结果正常3280例,子宫颈上皮内瘤变(CIN)Ⅰ级538例,CINⅡ级154例,CINⅢ级92例,子宫颈鳞癌(SCC)57例。检出率居前3位的HPV基因型依次为HPV52(15.83%)、HPV58(9.30%)、HPV16(9.29%)。在TCT结果正常、CINⅠ级、CINⅡ级、CINⅢ级、SCC者中,HPV52阳性者分别占15.82%、15.84%、18.01%、15.11%、12.16%,HPV58阳性者分别占8.87%、9.60%、14.22%、12.23%、13.51%,HPV 16阳性者分别占7.00%、9.94%、30.81%、31.65%、40.54%。HPV多重感染率为26.06%,多重感染在TCT结果正常、CINⅠ级、CINⅡ级、CINⅢ级、SCC者中分别占23.48%、40.52%、25.97%、35.87%、22.81%。HPV感染者中,高危型感染占80.40%;高危型HPV感染在TCT结果正常、CINⅠ级、CINⅡ级、CINⅢ级、SCC者中分别占78.42%、84.51%、94.31%、94.24%、95.95%。结论上海地区CINⅡ级、CINⅢ级和SCC患者HPV16感染率较高,HPV52在TCT结果正常和CINⅠ级女性中更常见。CINⅠ级患者HPV多重感染率较高。HPV分型在子宫颈癌及其癌前病变筛查中具有一定的临床意义。 展开更多
关键词 人乳头瘤病毒 基因型 液基细胞学检查 上海
暂未订购
HPVDNA分型检测在宫颈癌筛查中的应用
7
作者 李霞 焦得闯 +1 位作者 李玉宁 胡梦琪 《四川生理科学杂志》 2026年第3期620-622,625,共4页
目的:探究人乳头瘤病毒脱氧核糖核酸(Human Papillomavirus DNA,HPVDNA)分型检测在宫颈癌筛查中的应用价值。方法:选取2023年1月至2024年12月期间郑州诺森医学检验实验室94例宫颈癌筛查人员为研究对象,均实施HPVDNA分型检测、液基薄层细... 目的:探究人乳头瘤病毒脱氧核糖核酸(Human Papillomavirus DNA,HPVDNA)分型检测在宫颈癌筛查中的应用价值。方法:选取2023年1月至2024年12月期间郑州诺森医学检验实验室94例宫颈癌筛查人员为研究对象,均实施HPVDNA分型检测、液基薄层细胞(ThinPrep Cytologic Test,TCT)检测,以病理学检查结果为金标准。对比HPVDNA分型检测、TCT检测的诊断结果、诊断效能及HPVDNA分型检测、TCT检测的分级情况。结果:94例宫颈癌筛查人员中,金标准确诊阳性82例、阴性12例,应用HPVDNA分型检测阳性、阴性分别81例、13例,应用TCT检测阳性、阴性分别70例、24例;HPVDNA分型检测的准确性94.68%、灵敏度96.34%、特异度83.33%显著高于TCT检测的70.21%、75.61%、33.33%(P<0.05);HPVDNA分型检测阳性81例,阴性13例,低级73例,高级8例;TCT检测阳性70例,阴性24例,低级64例,高级6例。结论:在宫颈癌筛查中,HPVDNA分型检测具有较高应用价值,准确性、灵敏度及特异度较高,为临床早期制定个性化治疗方案提供依据。 展开更多
关键词 人乳头瘤病毒脱氧核糖核酸分型检测 液基薄层细胞检测 准确性 灵敏度
暂未订购
翻转课堂与CCPC教学相结合在医学检验技术专业脱落细胞学检验课程教改中的应用体会
8
作者 廖碧云 区敏敏 +2 位作者 詹新堂 王俊利 韦玉霞 《科学咨询》 2026年第4期156-160,共5页
脱落细胞学检验是医学检验技术专业的主要课程之一,是一门通过显微镜观察人体各部位的脱落细胞形态特点,为临床医生提供病理诊断依据的临床检验学科。然而,传统的教学模式难以满足培养脱落细胞学检验专业技术人才的教学需求,构建以学生... 脱落细胞学检验是医学检验技术专业的主要课程之一,是一门通过显微镜观察人体各部位的脱落细胞形态特点,为临床医生提供病理诊断依据的临床检验学科。然而,传统的教学模式难以满足培养脱落细胞学检验专业技术人才的教学需求,构建以学生为中心、注重互动参与和能力培养的新型教学模式势在必行。翻转课堂作为一种新兴的教学模式,通过将课堂内外的时间重新调整,将学习的决定权从教师转移给学生,提高了学生的自主学习能力和课堂参与度。CCPC(Clinical Care Program Certification,临床照护计划认证)教学强调通过流程再造、信息化支持、使用质量工具等方法,最大限度地遵从国际指南,提升医疗服务质量。本文将探讨翻转课堂与CCPC教学相结合在医学检验技术专业脱落细胞学检验课程中的应用体会,旨在为教学改革提供新的思路和方法。 展开更多
关键词 翻转课堂 CCPC教学 医学检验技术专业 脱落细胞学检验 教学改革
在线阅读 下载PDF
人乳头瘤病毒、薄层液基细胞学联合血清miR-182-3p、miR-885-5p对宫颈癌的价值
9
作者 解成霞 张元芳 赵延辉 《成都医学院学报》 2026年第1期65-68,共4页
目的探究人乳头瘤病毒(HPV)、薄层液基细胞学检查(TCT)联合血清miR-182-3p、miR-885-5p对宫颈癌筛查诊断的临床价值。方法选择2022年1月至2023年1月青海红十字医院收治的216例疑似宫颈癌患者为研究对象,根据手术及病理诊断结果(是否为... 目的探究人乳头瘤病毒(HPV)、薄层液基细胞学检查(TCT)联合血清miR-182-3p、miR-885-5p对宫颈癌筛查诊断的临床价值。方法选择2022年1月至2023年1月青海红十字医院收治的216例疑似宫颈癌患者为研究对象,根据手术及病理诊断结果(是否为宫颈癌),将其分为宫颈癌组(104例)和非宫颈癌组(112例)。采用qRT-PCR法测定两组血清miR-182-3p、miR-885-5p相对表达水平;绘制ROC曲线,评价HPV、TCT联合血清miR-182-3p、miR-885-5p水平对宫颈癌的诊断价值。结果经HPV检查诊断显示,诊断宫颈癌的灵敏度为75.00%、特异度为85.71%。经TCT检查诊断显示,诊断宫颈癌的灵敏度为78.85%、特异度为85.71%。与非宫颈癌组相比,宫颈癌组血清miR-182-3p表达水平升高(P<0.05),miR-885-5p表达水平降低(P<0.05)。HPV、TCT、miR-182-3p、miR-885-5p四者联合诊断宫颈癌的曲线下面积(AUC)最高,优于各指标诊断(P<0.05)。结论宫颈癌患者血清miR-182-3p水平升高,miR-885-5p水平降低,HPV、TCT联合血清miR-182-3p、miR-885-5p检测可提高宫颈癌的诊断效能。 展开更多
关键词 miR-182-3p miR-885-5p 人乳头瘤病毒 薄层液基细胞学检查 宫颈癌 筛查
暂未订购
HR-HPV E6/E7 mRNA检测联合TCT检查在宫颈病变中的临床应用价值
10
作者 梁静谊 区美娟 伍淑瑶 《中国现代医药杂志》 2026年第2期42-46,共5页
目的探讨高危型人乳头瘤病毒(HR-HPV)E6/E7 mRNA检测联合液基薄层细胞学检查(TCT)在宫颈癌及其早期病变筛查中的临床应用价值。方法选取2024年8月~2025年7月在我院接受宫颈病变筛查的144例女性作为研究对象,均进行HR-HPV E6/E7 mRNA检测... 目的探讨高危型人乳头瘤病毒(HR-HPV)E6/E7 mRNA检测联合液基薄层细胞学检查(TCT)在宫颈癌及其早期病变筛查中的临床应用价值。方法选取2024年8月~2025年7月在我院接受宫颈病变筛查的144例女性作为研究对象,均进行HR-HPV E6/E7 mRNA检测和TCT检查,并以阴道镜下病理活检结果作为诊断金标准。比较单一检测与联合检测的诊断效能,以及不同检测方法对不同级别宫颈病变的检出率。结果144例受试者经病理活检确诊阳性病例72例(其中早期宫颈病变CINⅠ33例、CINⅡ25例,占阳性病例的80.56%),阴性72例。HR-HPV E6/E7 mRNA检测阳性率为24.31%,TCT检查阳性率为29.86%,联合检测阳性率显著提高至48.61%。以病理结果为对照,联合检测的诊断准确率(97.22%)、特异度(98.61%)、灵敏度(95.83%)、阳性预测值(98.57%)和阴性预测值(95.95%)均显著高于单独的HR-HPV E6/E7 mRNA检测及TCT检查(P均<0.05)。在早期宫颈病变中,联合检测对CINⅠ的阳性检出率为96.97%,显著高于HR-HPV E6/E7 mRNA检测(42.42%)和TCT检查(48.48%);对CINⅡ的阳性检出率为96.00%,高于HR-HPV E6/E7 mRNA检测(44.00%)和TCT检查(64.00%),差异均有统计学意义(P<0.05)。且随着病理分级升高,三种检测方法的阳性检出率均呈上升趋势,联合检测的阳性检出率显著高于单一检测,差异具有统计学意义(P<0.05)。在高级别病变及癌变(CINⅢ、宫颈癌)中,三种检测方法的阳性检出率均较高,组间比较,差异无统计学意义(P>0.05)。结论在宫颈病变筛查中采取HR-HPV E6/E7 mRNA检测联合TCT检查能显著提高诊断准确性,减少漏诊、误诊情况,且能够用于早期宫颈病变的筛查。 展开更多
关键词 高危型人乳头瘤病毒 E6/E7 mRNA 液基薄层细胞学检查 宫颈病变 诊断效能
暂未订购
细胞学人工智能阅片、HPV联合检测在宫颈癌筛查中的应用研究及相关问题探讨
11
作者 陆建军 施晓懿 赵光明 《中国实用医药》 2026年第8期62-67,共6页
目的探讨细胞学人工智能(AI)阅片+人乳头瘤病毒(HPV)联合检测在宫颈癌筛查中的应用价值。方法回顾性分析3904例宫颈癌患者的筛查资料,基于中国子宫颈癌筛查指南中关于HPV和细胞学联合筛查异常管理流程,制定A方案为人工阅片+HPV检测,B方... 目的探讨细胞学人工智能(AI)阅片+人乳头瘤病毒(HPV)联合检测在宫颈癌筛查中的应用价值。方法回顾性分析3904例宫颈癌患者的筛查资料,基于中国子宫颈癌筛查指南中关于HPV和细胞学联合筛查异常管理流程,制定A方案为人工阅片+HPV检测,B方案为AI阅片+HPV检测。分析A方案中HPV感染分布情况以及A、B方案的诊断结果;比较A、B方案ASC-US、>ASC-US检出率;分析B方案AI阅片联合HPV检测的诊断效能;分析B方案中AI阅片假阴性资料。结果高危型HPV(-)、高危型HPV非16/18(+)、高危型HPV16/18(+)的病变率分别为1.66%(60/3625)、11.42%(25/219)、50.00%(30/60)。A方案中人工阅片结果未见上皮内病变或恶性细胞(NILM)3789例,经HPV检测高危型HPV(-)3565例,高危型HPV非16/18(+)194例,高危型HPV16/18(+)30例。基于疾病的风险程度分层,A方案不典型鳞状细胞(ASC-US)检出率2.02%低于B方案的3.92%(P<0.05);A方案>ASC-US检出率0.92%与B方案的0.85%比较,差异无统计学意义(P>0.05)。基于指南推荐的NILM、ASC-US、>ASC-US的分层管理模式下,B方案AI阅片联合HPV检测>ASC-US的阳性预测值96.97%、阴性预测值99.90%、灵敏度88.89%、特异度99.97%,检测ASC-US阳性预测值12.42%、阴性预测值98.40%、灵敏度24.05%、特异度96.50%。结论基于中国子宫颈癌筛查指南中关于HPV和细胞学联合筛查流程,细胞学AI阅片+HPV检测的宫颈癌筛查模式适用于宫颈癌筛查,可减少医疗负担、提升诊疗效率、保障筛查准确性展开。 展开更多
关键词 人工智能阅片 人乳头瘤病毒 液基细胞 宫颈癌筛查 联合检测
暂未订购
不同细胞学取样方法对肺癌诊断的意义及作用
12
作者 邓储婷 黎兵兵 +3 位作者 郑益红 黄慧春 林敏 黄加宾 《诊断病理学杂志》 2026年第1期100-104,共5页
目的比较分析纤维支气管镜刷片、肺泡灌洗液离心涂片(BALF)及纤维支气管镜刷液基薄层细胞学制片(TCT)中单种及联合检测方法。方法回顾性分析广东省人民医院赣州医院(赣州市立医院)2020年1月至2023年5月116例病理确诊肺癌患者的细胞学检... 目的比较分析纤维支气管镜刷片、肺泡灌洗液离心涂片(BALF)及纤维支气管镜刷液基薄层细胞学制片(TCT)中单种及联合检测方法。方法回顾性分析广东省人民医院赣州医院(赣州市立医院)2020年1月至2023年5月116例病理确诊肺癌患者的细胞学检查结果,比较刷片(n=109)、液基薄层制片(n=108)、灌洗液涂片(n=31)制片中单种及联合检测的阳性率,采用卡方检验进行统计学分析。结果116例肺癌确诊病例检测结果中,分析刷片、液基薄层制片(TCT)、灌洗液涂片(BALF)、刷片+液基薄层制片(TCT)、刷片+灌洗液涂片(BALF)、液基薄层制片(TCT)+灌洗液涂片(BALF)诊断阳性率分别为70.6%、69.4%、29.0%、78.8%、66.7%、66.7%。发现在单种检测方法中,刷片与液基薄层制片(TCT)阳性率无显著差异(70.6%vs 69.4%,P>0.05),均显著高于灌洗液涂片BALF(29.0%,P<0.001);联合检测中,刷片+TCT阳性率最高(78.8%),优于刷片+BALF(66.7%)或TCT+BALF(66.7%)(χ^(2)=27.996,P<0.001)。结论在肺癌细胞学筛查方式中,刷片与TCT单独检测效能相当,而二者联合可显著提高肺癌细胞学诊断阳性率,推荐作为临床优先选择的检测策略。 展开更多
关键词 肺癌 取样方法 细胞学 诊断效率 联合检测
原文传递
TCT联合高危型HPV检测对社区绝经后妇女机会性宫颈癌筛查的应用价值
13
作者 尹璐 张志亮 +1 位作者 张琳 叶兰 《癌变·畸变·突变》 2026年第1期22-26,共5页
目的:探讨宫颈液基薄层细胞学检测(TCT)联合高危型人乳头瘤病毒(HR-HPV)检测在社区绝经后妇女机会性宫颈癌筛查中的应用价值。方法:收集2021年11月—2024年12月在上海市普陀区卫生服务中心行机会性宫颈癌筛查的698名绝经后妇女的临床资... 目的:探讨宫颈液基薄层细胞学检测(TCT)联合高危型人乳头瘤病毒(HR-HPV)检测在社区绝经后妇女机会性宫颈癌筛查中的应用价值。方法:收集2021年11月—2024年12月在上海市普陀区卫生服务中心行机会性宫颈癌筛查的698名绝经后妇女的临床资料,纳入对象均行TCT、HR-HPV检测,筛查结果异常者于上级医院行阴道镜检查165名。最终以阴道镜活检病理诊断为金标准,对TCT、HR-HPV检测及两者联合检测的灵敏度、特异度、准确度等进行比较,采用受试者工作特征(ROC)曲线分析诊断效能。结果:TCT和HR-HPV检测的灵敏度分别为91.11%和92.22%,特异度均为48.0%,阳性预测值为67.77%和68.03%,阴性预测值为81.82%和83.72%,准确度为71.52%和72.12%;两者联合检测的灵敏度为97.78%,特异度为45.33%,阳性预测值为68.22%,阴性预测值为94.44%,准确率为73.94%。TCT和HR-HPV联合检测筛查宫颈癌的准确度和ROC曲线下面积均高于TCT或HPV(P<0.05)。结论:TCT联合HR-HPV检测筛查具有较高的诊断效能,可提升宫颈癌筛查的灵敏度,对绝经后妇女机会性宫颈癌筛查有较高的临床应用价值。 展开更多
关键词 绝经后妇女 宫颈癌 机会性筛查 宫颈液基薄层细胞检测 高危型人乳头状瘤病毒 联合筛查
暂未订购
p16/Ki-67双染检测对高危型人乳头瘤病毒患者癌前病变及宫颈癌的诊断价值
14
作者 林舒淇 周秀芬 +1 位作者 任俊 卞显凤 《妇儿健康导刊》 2026年第1期89-92,97,共5页
目的分析p16/Ki-67双染检测对高危型人乳头瘤病毒(HR-HPV)患者高级别鳞状上皮内病变及以上病变(HSIL+)的诊断价值。方法选取2024年8月至2025年4月于安徽医科大学附属六安医院就诊的HR-HPV阳性患者127例,进行宫颈液基薄层细胞学检查(TCT)... 目的分析p16/Ki-67双染检测对高危型人乳头瘤病毒(HR-HPV)患者高级别鳞状上皮内病变及以上病变(HSIL+)的诊断价值。方法选取2024年8月至2025年4月于安徽医科大学附属六安医院就诊的HR-HPV阳性患者127例,进行宫颈液基薄层细胞学检查(TCT)、p16/Ki-67双染检测及阴道镜宫颈活检。以病理检查结果作为金标准,比较TCT与p16/Ki-67双染检测对HR-HPV阳性患者HSIL+的诊断效能。结果HRHPV分型中,HPV52为最常见亚型,其次为HPV16和HPV58。与TCT相比,p16/Ki-67双染检测对HSIL+的敏感性和阴性预测值更高(P<0.05)。p16/Ki-67双染检测和TCT的Kappa值分别为0.541和0.228。结论在HR-HPV阳性患者HSIL+的筛查和诊断中,与TCT相比,p16/Ki-67双染检测诊断效能更优,具有较高的临床应用价值。 展开更多
关键词 p16/Ki-67双染检测 液基薄层细胞学检查 高危型人乳头瘤病毒 高级别鳞状上皮内病变
暂未订购
p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening 被引量:18
15
作者 Qin Han Hongyan Guo +1 位作者 Li Geng Yanjie Wang 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2020年第2期208-217,共10页
Objective:To evaluate the efficiency of p16/Ki-67 dual stain used as a triage in cervical cancer screening.Methods:In this study,we did 468 p16/Ki-67 dual stain in human papillomavirus(HPV)16/18-positive or 12 other h... Objective:To evaluate the efficiency of p16/Ki-67 dual stain used as a triage in cervical cancer screening.Methods:In this study,we did 468 p16/Ki-67 dual stain in human papillomavirus(HPV)16/18-positive or 12 other high-risk HPV(OHR-HPV)positive Thinprep cytologic test(TCT)atypical squamous cells of undetermined significance(ASCUS)/lower-grade squamous intraepithelial lesion(LSIL)women.We evaluated the sensitivity,specificity,positive predictive value(PPV)and negative predictive value(NPV)of the triage test.Results:The sensitivity,specificity,PPV and NPV of p16/Ki-67 dual stain in HPV 16/18-positive women were91.5%/68.4%,77.0%/75.0%,73.9%/59.1%and 92.8%/81.8%.In 12 OHR-HPV positive TCT ASCUS/LSIL women,the results were 79.1%/95.0%,88.5%/66.7%,88.5%/70.4%and 89.2%/94.1%.The risk of precancerous lesions in p16/Ki-67 dual stain positive cases was much higher than before,and the negative cases had lower risk.Besides,there was no cervical intraepithelial neoplasia(CIN)III case missed after triaged by p16/Ki-67 dual-stained cytology.In p16/Ki-67 dual-stained cytology positive women with benign pathology or CIN I,the 1-year progression rate is 20.5%and in p16/Ki-67 dual-stained cytology negative women,the 1-year progression rate is5.6%.Conclusions:hr-HPV genotyping test plays an important role in cervical cancer screening.p16/Ki-67 dual stain may be a promising triage test.As for chronic cervicitis or CIN I patients,a positive p16/Ki-67 dual-stained cytology suggests a high risk in progression and need to be followed up closely. 展开更多
关键词 Cervical cancer screening hr-HPV genotyping test p16/Ki-67 dual-stained cytology triage test
暂未订购
Genetic testing vs microforceps biopsy in pancreatic cysts:Systematic review and meta-analysis 被引量:2
16
作者 Sandra Faias Luisa Pereira +2 位作者 Angelo Luis Paula Chaves Marilia Cravo 《World Journal of Gastroenterology》 SCIE CAS 2019年第26期3450-3467,共18页
BACKGROUND Carcinoembryonic antigen(CEA)and cytology in pancreatic cystic fluid are suboptimal for evaluation of pancreatic cystic neoplasms.Genetic testing and microforceps biopsy are promising tools for pre-operativ... BACKGROUND Carcinoembryonic antigen(CEA)and cytology in pancreatic cystic fluid are suboptimal for evaluation of pancreatic cystic neoplasms.Genetic testing and microforceps biopsy are promising tools for pre-operative diagnostic improvement but comparative performance of both methods is unknown.AIM To compare the accuracy of genetic testing and microforceps biopsy in pancreatic cysts referred for surgery.METHODS We performed a literature search in Medline,Scopus,and Web of Science for studies evaluating genetic testing of cystic fluid and microforceps biopsy of pancreatic cysts,with endoscopic ultrasound with fine-needle aspiration(EUSFNA)prior to surgery and surgical pathology as reference standard for diagnosis.We evaluated the diagnostic accuracy for:1-benign cysts;2-mucinous low-risk cysts;3-high-risk cysts,and the diagnostic yield and rate of correctly identified cysts with microforceps biopsy and molecular analysis.We also assessed publication bias,heterogeneity,and study quality.RESULTS Eight studies,including 1206 patients,of which 203(17%)referred for surgery who met the inclusion criteria were analyzed in the systematic review,and seven studies were included in the meta-analysis.Genetic testing and microforceps biopsies were identical for diagnosis of benign cysts.Molecular analysis was superior for diagnosis of both low and high-risk mucinous cysts,with sensitivities of 0.89(95%CI:0.79-0.95)and 0.57(95%CI:0.42-0.71),specificities of 0.88(95%CI:0.75-0.95)and 0.88(95%CI:0.80-0.93)and AUC of 0.9555 and 0.92,respectively.The diagnostic yield was higher in microforceps biopsies than in genetic analysis(0.73 vs 0.54,respectively)but the rates of correctly identified cysts were identical(0.73 with 95%CI:0.62-0.82 vs 0.71 with 95%CI:0.49-0.86,respectively).CONCLUSION Genetic testing and microforceps biopsies are useful second tests,with identical results in benign pancreatic cysts.Genetic analysis performs better for low-and high-risk cysts but has lower diagnostic yield. 展开更多
关键词 Pancreatic CYSTS ENDOSCOPIC ULTRASOUND ENDOSCOPIC ULTRASOUND with fineneedle ASPIRATION Genetic testing Microforceps BIOPSY Molecular analysis KRAS Carcinoembryonic antigen cytologY
暂未订购
Effectiveness of Co-Testing in Cervical Cancer Screening Program in Macao SAR
17
作者 Lamlam Chan Kamweng Wong 《Health》 2024年第8期763-769,共7页
Background: Cervical cancer remains a significant public health concern in Macao SAR despite the implementation of a cervical cancer screening program and HPV vaccination. To improve early detection, Macao SAR introdu... Background: Cervical cancer remains a significant public health concern in Macao SAR despite the implementation of a cervical cancer screening program and HPV vaccination. To improve early detection, Macao SAR introduced HPV DNA testing alongside cytology (co-testing) as the primary screening method in 2019. This study evaluates the effectiveness of co-testing in identifying cervical precancerous lesions (CIN2+) compared to cytology alone. Methods: We conducted a retrospective analysis of women aged 30 - 65 years who participated in the routine cervical cancer screening program in Macao SAR Primary Healthcare Centers from 2019 to 2022. Data from over 70,000 women were analyzed, comparing the detection rates of CIN2+ through co-testing and cytology alone. Women with abnormal cytology or positive HPV results were referred for colposcopy. Results: The introduction of co-testing led to a significant increase in the detection of CIN2+, particularly in women with atypical squamous cells of undetermined significance (ASCUS) or negative for intraepithelial lesion or malignancy (NILM) cytology results. Between 2019 and 2022, the percentage of women with ASCUS/NILM and any high-risk HPV (hrHPV) positive who were diagnosed with CIN2+ after colposcopy were 24%, 13%, 10% and 7.5% respectively. This highlights the ability of co-testing to identify high-risk individuals who would have been missed by cytology alone. Discussion: Our findings demonstrate the effectiveness of co-testing in improving the sensitivity of cervical cancer screening in Macao SAR. The inclusion of HPV DNA testing allows for better risk stratification of women with ASCUS/NILM cytology, leading to more targeted referrals for colposcopy and timely detection of precancerous lesions. The initial high positive rate in 2019 (24%) might be attributed to the small sample size and potentially reflects a backlog of undiagnosed cases prior to co-testing implementation. Conclusion: The implementation of co-testing in Macao SAR’s cervical cancer screening program significantly improves the early detection of precancerous lesions, particularly in women with ambiguous cytology results. This proactive approach contributes to reducing cervical cancer morbidity and mortality and improving women’s health outcomes in Macao SAR. 展开更多
关键词 Cervical Cancer Co-testing HPV DNA testing Liquid-Based cytology Thin Prep COLPOSCOPY Cervical Cancer Screening Program
暂未订购
Correlative analysis between abnormal cervical cytology and pathology of vaginoscopic biopsy or conization 被引量:1
18
作者 李彩娟 郎景和 +1 位作者 程雪梅 王友芳 《生殖医学杂志》 CAS 2006年第B10期69-73,共5页
Objectives: To evaluate the predictive value of cervical intraepithelial neoplasia (CIN)III/ carcinoma in situ (CIS) by correlating analysis between abnormal cervical cytologic findings and pathological diagnosis of v... Objectives: To evaluate the predictive value of cervical intraepithelial neoplasia (CIN)III/ carcinoma in situ (CIS) by correlating analysis between abnormal cervical cytologic findings and pathological diagnosis of vaginoscopic biopsies or conization.Methods: Routine cervical cytology screening was performed in 31,634 cases by fluid-based thin-layer method (ThinPrep cytology test, TCT), 948 patients had both abnormal squamous cell appearance by TCT and pathological diagnosis of vaginoscopic biopsies and /or cervical conization. The predictive value of CINIII/CIS were studied retrospectively by correlating analysis of different cytology abnormalities and pathology diagnosis.Results: Cytologically, 1,260 out of 31,634 TCT tests showed abnormal squamous cells appearance, including atypical squamous cell of undetermined significance (ASCUS) 675 cases(2.13%), low squamous intraepithelial lesion (L-SIL) 379 cases(1.20%), high squamous intraepithelial lesion (H-SIL)176 cases(0.56%),cancer 30 cases (0.09%). Among 948 patients with pathological diagnosis, there were CINII-III in 70 cases(7.38%) and CINIII/CIS in 56 cases.(5.91%). The relative risks (RR) of different precancerous TCT results in predicting CIN III/CIS validated by pathology are as follow: AUSCUS 14.7% (95% confidence interval (CI) 8.0-27.0), Lsil 13.9% (95% CI 6.3-30.9), Hsil 126.1 (95% CI 60.6-218.6). The RR of AUSCUS group is not significantly different from that of L-SIL group(P =0.951). However, the RR of CINⅢ/CIS morbidity between the H-SIL or cancer group and the ASCUS or L-SIL group are significantly different (all P value <0.01).Conclusion: Vaginoscopic biopsy could verify pathological CINⅡ-Ⅲ and CINⅢ/CIS from cases with abnormal TCT results. There is significantly greater risk of being CINⅢ/CIS validated by vaginoscopic biopsy in the H-SILpatients,while ASCUS and L-SIL group have the coequal risk. 展开更多
关键词 子宫颈肿瘤 细胞学 病理学 活组织检查
暂未订购
Concordance in the Interpretation of Cervical Cytology for the Early Diagnosis of Cervical Cancer
19
作者 Sandra Olimpia Gutiérrez-Enríquez Luis Chávez-Hernández +5 位作者 Yolanda Terán-Figueroa Darío Gaytán-Hernández Cuauhtémoc Oros-Ovalle Verónica Gallegos-García Aracely Diáz-Oviedo Claudia Elena González-Acevedo 《Open Journal of Obstetrics and Gynecology》 2016年第12期714-724,共12页
Objective: To identify the diagnostic concordance in the interpretation of cervical smears. Material and Methods: Cross-sectional study from October 2011 to January 2013. 50 samples were read by every 4 cyto-technolog... Objective: To identify the diagnostic concordance in the interpretation of cervical smears. Material and Methods: Cross-sectional study from October 2011 to January 2013. 50 samples were read by every 4 cyto-technologists who are the total staffs that read and interpret cytological specimens from a public health institution of the city of San Luis Potosí, México. The cytological diagnosis was confirmed by a certified pathologist. Checklist was developed to determine the quality of the interpretation composed of three sections: adequate sample, inadequate sample and cytological diagnosis. The diagnostic report was made by Bethesda System 2001 classification. Diagnostic concordance was measured through the Kappa coefficient. To establish the differences in cytological diagnosis between each cyto-technologist, chi square test was applied. Results: The concordance is acceptable in the classification of samples as inadequate (k = 0.66). The negative diagnosis was a significant concordance between each cytotechnologist and pathologist;however, no case had very good concordance. In the epithelial abnormalities, only the cytotechnologist 2 had significant concordance with the pathologist, however, its concordance is low. In the case of glandular abnormalities, only cytotechnologist 1 had no significant concordance with the pathologist. The percentage of true negatives was 30%, true positives 20%, false negatives 50% and false positives 0 %. There are significant differences between the readings of cyto-technologist 1 and 2 (p < 0.008), between 1 to 4 (p < 0.001), between 2 and 3 (p < 0.05), and finally between 3 and 4 (p < 0.003). Conclusions: The concordance between cyto-technologists and pathologists is below the required minimum level set by national and international standards. 展开更多
关键词 Papanicolaou test Cervical Cancer Quality Control cytologY
暂未订购
TruScreen联合高危HPV检测与液基细胞学联合HPV检测在宫颈癌筛查中的对比研究 被引量:2
20
作者 杨益 李春梅 +3 位作者 贾蜀云 王以锋 王登攀 张力尹 《四川大学学报(医学版)》 北大核心 2025年第3期852-857,共6页
目的对比人工智能宫颈癌实时筛查技术(TruScreen)联合高危人乳头瘤病毒(high-risk human papillomavirus,hr-HPV)检测与液基薄层细胞学检测(Thinprep cytologic test,TCT)联合hr-HPV在宫颈癌筛查中的临床价值。方法研究对象为2020年6月... 目的对比人工智能宫颈癌实时筛查技术(TruScreen)联合高危人乳头瘤病毒(high-risk human papillomavirus,hr-HPV)检测与液基薄层细胞学检测(Thinprep cytologic test,TCT)联合hr-HPV在宫颈癌筛查中的临床价值。方法研究对象为2020年6月–2023年12月期间在攀枝花市中心医院接受宫颈癌筛查的297例女性,筛查项目包括HPV检测、TCT检测以及TruScreen检测。以病理结果为标准,评估TruScreen联合hr-HPV与TCT联合hr-HPV对宫颈低度鳞状上皮内病变(low-grade squamous intraepithelial lesion positive,LSIL^(+))及高度鳞状上皮内病变(high-grade squamous intraepithelial lesion positive,HSIL^(+))的诊断效果。结果在297例受试者中,病理确诊LSIL^(+)128例(43.10%),HSIL^(+)67例(22.56%)。HPV16/18阳性110例(37.04%),TCT检测≥未明确诊断意义的非典型鳞状细胞(atypical squamous cells of undetermined significance,ASC-US)177例(59.60%),176例(59.26%)TruScreen检测异常;TruScreen联合hr-HPV诊断LSIL^(+)及HSIL^(+)宫颈病变的曲线下面积(area under the curve,AUC)高于TCT联合hr-HPV(P<0.05)。结论TruScreen联合hr-HPV在宫颈癌筛查中的效果优于TCT联合hr-HPV,可作为传统细胞学检查的潜在替代方案,具有较高的临床应用价值。 展开更多
关键词 宫颈肿瘤 人工智能 高危人乳头瘤病毒 液基细胞学 宫颈癌筛查
原文传递
上一页 1 2 61 下一页 到第
使用帮助 返回顶部